Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2014; 20(25): 8229-8236
Published online Jul 7, 2014. doi: 10.3748/wjg.v20.i25.8229
Figure 4
Figure 4 Growth inhibition of colorectal cancer cell lines by oxaliplatin in combination with adriamycin. A: Growth inhibition of SW620 cells; B: Growth inhibition of SW480 cells; C: Growth inhibition of HCT116 cells. aP < 0.05.